Axolabs is a contract research, development, and manufacturing organization (CRDMO) specializing in oligonucleotide and nucleic acid therapeutics. The company provides integrated services from lead identification through preclinical and clinical development to commercial supply. Axolabs operates as part of the LGC Group, offering tailored solutions to pharmaceutical and biotechnology clients globally.